MS-39
K号: K221601 · 2023-09-01
广告
决定日期2023-09-01
产品代码OBO
咨询委员会OP
请注意，由于您没有提供具体的医疗设备监管文本，我无法进行翻译。请提供具体的文本内容，以便我能够按照您的要求进行翻译。
决定实质等同
器械摘要
MS-39 is the device name listed in this FDA 510(k) record. The listed applicant is C.S.O. S.R.L.. It received FDA 510(k) clearance on 2023-09-01 under 510(k) number K221601. The device is classified under product code OBO. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the MS-39?
MS-39 is a medical device that received FDA 510(k) clearance on 2023-09-01. The listed applicant is C.S.O. S.R.L.. The 510(k) number is K221601.
When did MS-39 receive FDA 510(k) clearance?
MS-39 received FDA 510(k) clearance on 2023-09-01, under 510(k) number K221601.
Who is the listed applicant for MS-39?
The FDA 510(k) record lists C.S.O. S.R.L. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for MS-39?
The FDA product code for MS-39 is OBO.
相关器械（代码：OBO）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
K261019安特里昂Heidelberg Engineering GmbHK253837SPECTRALIS HRA+OCT及其变体；SPECTRALIS带Flex模块Heidelberg Engineering GmbHK252633UNITY DX (UDX)Cylite Pty. , Ltd.K250553Tomey 角膜/眼前节光学相干断层扫描仪（CASIA2）Tomey CorporationK250868SPECTRALIS HRA+OCT及其变体Heidelberg Engineering GmbHK240924AnterionHeidelberg Engineering GmbH
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告